NKY Pharma (新开源制药)

Boai NKY Pharmaceuticals Ltd (NKY, stock code: 300109) was the first domestic company to develop and manufacture polyvinylpyrrolidone (PVP) series products in China. With more than 27 year’s experience in PVP production coupled to a dedicated commitment to quality improvement and management, NKY has become the largest Chinese producer of PVP’s and third largest globally.

Read more ↓
Report
Tired of ads? Enjoy an ad-free experience by signing up.
The company isn't hiring currently. But don't let it stop you.

Review

By reading these reviews and ratings, you agree to Tech in Asia’s terms of use.

Unlock unlimited company data

Subscribe

As our subscriber, you can search and filter over 100,000 companies for your fundraising, investing, or sales needs.

Just $0.17 per day

Sign up and view for free

Register for a Basic account and view “NKY Pharma (新开源制药)” profile for free

Our subscriber community includes professionals from these companies:

Similar companies

KosmodeHealth

2 – 10 employees

0 job positions

Tired of ads? Enjoy an ad-free experience by signing up.